FDA inspection

Hangzhou Leading Pharmatech Co., Ltd.: FDA inspection ending Nov 8, 2024

FDA inspection 1256777 · No Action Indicated (NAI) · Hangzhou

Key facts

Inspection ID 1256777
Firm Hangzhou Leading Pharmatech Co., Ltd.
FEI number 3017262460
Address Building Seventh Floor, 4 Wenyi West Rd; Yuhang
City Hangzhou
Fiscal year 2025
Inspection end date Nov 8, 2024
Classification No Action Indicated (NAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections